Clinical Considerations - Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
- Centers for Disease Control and Prevention
- All Healthcare Organizations
According to the U.S. Centers for Disease Control and Prevention (CDC), since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults. There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson).
In most cases, patients who presented for medical care have responded well to medicatio…Sign Up for Free Trial